Fatty liver sounds harmless. But it isn’t. It’s a condition where excess fat builds up in the liver, and over time, it can ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.
Blocking Caspase-2 (the liver’s guardian enzyme) to treat fatty liver may produce chronic damage and multiply the risk of ...
Year-end festivities have led to an 8.9 per cent rise in liver function abnormalities among India Inc employees, driven by ...
Some high-dose detox “natural” supplements, such as green tea extract, can lead to liver inflammation, reflected in elevated ...
A new analysis links short and long sleep duration to markers of chronic liver disease, highlighting sleep as a potential ...
New research has shown that inhibiting caspase-2 to treat fatty liver disease may increase inflammation, fibrosis and cancer ...
News Medical on MSN
Blocking liver enzyme Caspase-2 may increase long-term cancer risk
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age. In a major new ...
New population-level research has found a link between abnormal sleep duration and an increased risk of chronic liver disease, indicating that sleep patterns may play an important role in liver health ...
In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.
Investor's Business Daily on MSN
The gene-editing news that sent beleaguered Intellia Therapeutics stock up
Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results